Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery
Launched by CAIRO UNIVERSITY · Jun 25, 2025
Trial Information
Current as of July 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help reduce anxiety in adults who are having a specific eye surgery called Dacryocystorhinostomy (DCR), which is done under general anesthesia. The study compares two methods: using virtual reality (VR) to help patients relax before surgery, and giving a common anti-anxiety medicine called Midazolam. The goal is to see which method works better to keep patients calm and stable during the procedure.
Adults aged 18 to 65 who are generally healthy and scheduled for DCR surgery may be able to join the study. People with heart or kidney problems, certain mental health conditions, or those who feel uncomfortable with VR or have issues like severe eye irritation won’t be eligible. If you join, you’ll either wear a VR headset to help distract and relax you before surgery or receive the usual medication. The researchers will then monitor how well each method helps reduce anxiety and keeps your vital signs steady. This study aims to find a comfortable and safe way to ease patients’ worries before surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-65.
- • Both sexes.
- • American Society of Anesthesiologists (ASA) classification: I - II.
- • Patient undergoing Dacryocystorhinostomy Surgery (DCR) operation under general anesthesia.
- Exclusion Criteria:
- • Patient refusal.
- • Patients with cardiac diseases.
- • Patients with renal diseases.
- • Patients with drug sensitivity and seizures.
- • Substance abuse and addiction.
- • Claustrophobia.
- • Patients with cerebrovascular disease.
- • Psychiatric and cognitive disorder.
- • Patients with severe teary eyes and blurring of vision.
- • Patients who express discomfort during the test.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported